Ascidian Therapeutics logo

Ascidian Therapeutics

Rewriting RNA

48 employees · est. 2020 · Boston, United States

VS
Shape Therapeutics Inc. logo

Shape Therapeutics Inc.

The future of programmable RNA Medicines

32 employees · est. 2018 · Seattle, United States

Shape Therapeutics Inc. is the older company (2020 vs 2018).

Side-by-Side Comparison

Ascidian Therapeutics Shape Therapeutics Inc.
Founded
2020 2018 older
Headquarters
Boston, United States Seattle, United States
Employees
48 32
Industry
Biotechnology, Health and Wellness Biotechnology
Funding Stage
Series A Series B
Total Funding
$90.00M $147.50M
Funding Rounds
3 3
Services
RNA exon editing platform, Developing RNA-based medicines, Manufacturing partnership for RNA therapies Development of programmable RNA medicines, AI-driven genetic research and analysis, Design and manufacturing of RNA therapeutics, Precise delivery systems for RNA medicines
Target Customers
Patients with genetic diseases, Healthcare professionals, Biotechnology researchers Healthcare providers, Biopharmaceutical companies, Research institutions, Patients with genetic disorders
Taxonomy
RNA Therapeutics, Gene Editing, Post-transcriptional Editing, Ophthalmology, Neurological Disorders, Neuromuscular Disorders, Rare Diseases, Functional Proteins, Exon Editing, Disease Treatment, Precision Medicine, Preclinical Programs, Therapeutic Innovation Programmable RNA Medicines, RNA Gene Therapy, AI In Biotechnology, RNA Editing, Gene Editing, Next-Generation AAVs, Neurodegenerative Disease Treatment, Rare Genetic Disorder Therapies, Alzheimer's Treatment, Parkinson's Treatment, Gene Therapy Manufacturing, Therapeutic Development, Metabolic Disease Treatment, Biotechnology Innovations, Pharmaceutical Collaborations
Website
ascidian-tx.com shapetx.com
Ascidian Therapeutics logo

About Ascidian Therapeutics

Ascidian Therapeutics, founded in 2020, is a pioneering company in the Biotechnology and Health and Wellness industries, headquartered in the United States. Their slogan, "Rewriting RNA," encapsulates their innovative approach to disease treatment by focusing on RNA editing. By targeting exons at th...

Shape Therapeutics Inc. logo

About Shape Therapeutics Inc.

Shape Therapeutics Inc., founded in 2018, is redefining the Biotechnology landscape with its focus on innovative RNA medicines. With its headquarters in the United States, the company positions itself at the forefront of genetic disorder solutions, merging AI with cutting-edge RNA technology to expl...

We will tell you when either one moves

BounceWatch watches Ascidian Therapeutics and Shape Therapeutics Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ascidian Therapeutics and Shape Therapeutics Inc... — by email.

Frequently Asked Questions

Ascidian Therapeutics — Rewriting RNA. Shape Therapeutics Inc. — The future of programmable RNA Medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ascidian Therapeutics has raised $90.00M while Shape Therapeutics Inc. has raised $147.50M.
Ascidian Therapeutics and Shape Therapeutics Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ascidian Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ascidian Therapeutics on 9 Jun 2026, and Shape Therapeutics Inc. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes